Navigation Links
HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008'
Date:10/14/2008

HealthTalker Founder and CEO Andrew Levitt to showcase HealthTalker at 'Health and Pharma 2.0' session.

Somerville, MA (PRWEB) October 14, 2008 -- HealthTalker, www.healthtalker.com, the word-of-mouth marketing (WOM) firm for the pharmaceutical and biotechnology industries, today announced that Andrew Levitt, Founder and CEO of HealthTalker, will be featured on the panel "Pharma and Health 2.0" at Health 2.0: User-Generated Healthcare 2008, October 23, in San Francisco.

Levitt will demonstrate Heathtalker's innovative WOM pharmaceutical marketing program, http://www.healthtalker.com/site/about, and share insights on influencing and leveraging the untapped power of consumer conversation. He will discuss the power of consumers speaking to people they know about their health experiences and how WOM can work in this highly-regulated industry.

A list of the other panelists showcasing can be found at www.health2con.com/sf08.html. The session will take place at the San Francisco Marriott at 4:00 p.m., October 23.

"It's really important for pharmaceutical companies to evolve their marketing approach, and challenge the status quo," said Andrew Levitt, Founder and CEO of HealthTalker. "Consumer trust is at an all-time low, and patients are craving a sense of connectivity with the brands they use on a daily basis. Give them a voice and the right tools, and you can create a consumer-to-consumer program that brings a degree of credibility and authenticity to the discussion that no traditional advertisement can match," he said.

Health 2.0: User-Generated Healthcare 2008 provides a sweeping overview of the things that are happening in Web 2.0, from technologies to healthcare. Health 2.0 covers everything from innovations in search and healthcare-focused social networks and consumer sites to exciting trends in wellness and personalized medicine taking shape on the horizon.

About HealthTalker

HealthTalker is a Boston-based, full-service (WOM) agency that develops innovative programs for the healthcare market with a specific focus on the pharmaceutical and biotechnology industries. HealthTalker programs recruit highly engaged patients and/or caregivers to participate in multi-faceted offline and online experiences that are personally relevant to them. Through their conversations with others, HealthTalker members help raise awareness of health conditions and treatment options, which may lead to better physician-patient dialogue. HealthTalker monitors the spread and impact of its programs via a custom, proprietary software platform that captures metrics across multiple channels. This unique and flexible application also allows HealthTalker to accommodate the specific needs and requirements of the industry. Learn more at http://www.healthtalker.com/site/story.

Contact: Debby Fireman | debby @ fireworksbydesign.com | 610.547.2229

###

Read the full story at http://www.prweb.com/releases/2008/10/prweb1460054.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Help for Stutterers on The Doctors TV Show Presented by Power Stuttering Center Founder Mark Power
2. GetResearchSmart LLC Website Founder Honored as Guest Editor
3. Playboy founder embodies American Dream; changes American culture
4. FemmePharma Founder Honored by PharmaVOICE
5. Group RCI Gifts $100,000 to Christel House International Founder at Company Block Party
6. Sunrise Senior Living Founder and CEO to Become Chairman
7. The Chopra Center Co-founders Will Teach a Beginning Course in Meditation and Mind-body Healing This August in Chicago
8. The Chopra Center Co-founders Bring Mind-Body Healing to New York City
9. Statement by Steve Case, Co-Founder, AOL and Chairman of Accelerate Brain Cancer Cure (www.ABC2.org) on News of Senator Ted Kennedys Brain Cancer Diagnosis
10. American Lung Association Founder Honored With New U.S. Postage Stamp
11. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: